Cristina Gervasoni
Overview
Explore the profile of Cristina Gervasoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
1603
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Testa J, Cattaneo D, Giacomelli A, Lai A, Ridolfo A, Gori A, et al.
AIDS
. 2025 Mar;
39(5):625-626.
PMID: 40080172
No abstract available.
2.
Mazzitelli M, Cozzolino C, Gervasoni C, Pagano S, Reato S, Ripamonti D, et al.
J Antimicrob Chemother
. 2025 Feb;
PMID: 39928421
Background: Even though the doravirine/dolutegravir combination is not mentioned by guidelines, real-life data has begun to emerge on its use. We aimed to describe the durability of doravirine/dolutegravir in a...
3.
Carrozzo G, Caloni B, Giacomelli A, Oreni L, Caronni S, Lazzarin S, et al.
Int J Cardiol
. 2024 Nov;
420:132742.
PMID: 39566586
Background: People with HIV (PWH) are at increased risk of atherosclerotic cardiovascular disease (ASCVD). Lowering low-density lipoprotein cholesterol (LDL-C) is central of cardiovascular disease prevention. The aim of this study...
4.
Cattaneo D, Ridolfo A, Giacomelli A, Castagna A, Dolci A, Antinori S, et al.
Ther Drug Monit
. 2024 Sep;
47(2):309-312.
PMID: 39235337
Background: Antiretroviral drug combinations affect dolutegravir trough concentrations. Here, the authors focused on dolutegravir plus booster darunavir antiretroviral regimens to investigate the effect of the booster and/or timing of drug...
5.
Giacomelli A, Ciubotariu C, Zacheo M, Rabbione A, Pieruzzi M, Barone F, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066168
The aim of this study was to assess the prevalence of inappropriate treatment among hospitalised patients affected by SARS-CoV-2 infection before hospital admission during the Omicron era. This single-centre, retrospective...
6.
Cattaneo D, Gervasoni C
Expert Rev Clin Pharmacol
. 2024 Jun;
17(7):579-587.
PMID: 38829318
Introduction: The treatment of HIV infection has been revolutionized in recent years thanks to the advent of dual antiretroviral regimens, administered orally or as long-acting injectable formulations. Here, we provide...
7.
Cattaneo D, Giacomelli A, Calvagna N, Bonini I, Ridolfo A, Gervasoni C
Ther Drug Monit
. 2024 May;
46(4):419-421.
PMID: 38758630
Objective: Preliminary evidence shows that concomitant administration of valproic acid can reduce the exposure to dolutegravir with limited clinical impacts. Here, we describe a male living with HIV who experienced...
8.
Cattaneo D, Caloni B, Caronni S, Calvagna N, Bonini I, Giacomelli A, et al.
Ther Drug Monit
. 2024 May;
46(3):277-280.
PMID: 38723113
Background: Carbamazepine (CBZ) is an antiseizure medication known to induce the expression of cytochrome P4503A metabolic enzymes. Here, we describe a man living with HIV who underwent several changes in...
9.
Giacomelli A, Cattaneo D, Pozza G, Moschese D, Cossu M, Dalu D, et al.
J Antimicrob Chemother
. 2024 Apr;
79(7):1708-1709.
PMID: 38661237
No abstract available.
10.
Cossu M, DAvolio A, Gervasoni C, Giacomelli A, Cattaneo D, Moschese D
Antimicrob Agents Chemother
. 2024 Mar;
68(5):e0017524.
PMID: 38534104
No abstract available.